Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT05620407

Public ClinicalTrials.gov record NCT05620407. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population.

Study identification

NCT ID
NCT05620407
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
513 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2023 (Actual)
Primary completion
Oct 19, 2026 (Estimated)
Completion
Nov 13, 2028 (Estimated)
Last update posted
Dec 2, 2025

2023 – 2028

United States locations

U.S. sites
39
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Local Institution - 0063 La Jolla California 92037 —
Local Institution - 0241 La Mesa California 91942 —
Local Institution - 0242 San Diego California 92128 —
Local Institution - 0143 San Leandro California 94578 —
Local Institution - 0147 Santa Monica California 90404 —
Local Institution - 0213 Clearwater Florida 33765 —
Local Institution - 0059 Jacksonville Florida 32256 —
Local Institution - 0075 Margate Florida 33063 —
Local Institution - 0007 Oakland Park Florida 33334 —
Local Institution - 0239 Plant City Florida 33160 —
Emory University School of Medicine- Grady Campus Atlanta Georgia 30303 —
Local Institution - 0137 Marietta Georgia 30060 —
Local Institution - 0089 Orland Park Illinois 60467 —
Local Institution - 0041 Skokie Illinois 60076 —
Local Institution - 0231 New Orleans Louisiana 70112 —
Local Institution - 0060 Boston Massachusetts 02114 —
Local Institution - 0056 Boston Massachusetts 02215 —
Local Institution - 0084 Worcester Massachusetts 01605 —
Local Institution - 0152 Grand Blanc Michigan 48439 —
Local Institution - 0072 Rochester Minnesota 55905 —
Local Institution - 0216 Las Vegas Nevada 89102 —
Local Institution - 0165 Paramus New Jersey 07652 —
Local Institution - 0069 Brooklyn New York 11201 —
Local Institution - 0217 Great Neck New York 11021 —
Local Institution - 0150 New York New York 10021 —
Local Institution - 0102 New York New York 10032 —
Local Institution - 0145 Syracuse New York 13210 —
Local Institution - 0178 Charlotte North Carolina 28210 —
Local Institution - 0005 Cleveland Ohio 44106 —
Local Institution - 0043 Oklahoma City Oklahoma 73104 —
Local Institution - 0205 Pittsburgh Pennsylvania 15224 —
Local Institution - 0081 Charleston South Carolina 29425 —
Local Institution - 0225 Florence South Carolina 29501 —
Local Institution - 0002 Jackson Tennessee 38305 —
Local Institution - 0001 Colleyville Texas 76034 —
Local Institution - 0164 El Paso Texas 79902 —
Local Institution - 0169 Katy Texas 77494 —
Local Institution - 0201 Temple Texas 76508 —
Local Institution - 0133 Danville Virginia 24541 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 141 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05620407, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05620407 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →